Drug delivery from structured porous inorganic materials

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 4, Issue 1, 2012, Pages 16-30

  Arruebo, Manuel ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOADHESIVES; BIOLOGICAL PAYLOADS; DIFFUSION RATE; DRUG DELIVERY APPLICATIONS; DRUG RELEASE; DRUG RESERVOIR; ENCAPSULATED DRUGS; GASTROINTESTINAL TRACT; LARGE PORE VOLUME; LARGE SURFACE AREA; LOW DENSITY; MICROFABRICATED; PHYSIOLOGICAL CONDITION; POORLY SOLUBLE DRUGS; PORE VOLUME; POROUS INORGANIC MATERIALS; POROUS MEMBRANES; POROUS STRUCTURES; SURFACE FUNCTIONALIZATION; TARGETED DRUG DELIVERY; TRIGGERING SYSTEMS;

CHEMICAL STABILITY; DIFFUSION COATINGS; GENES; MECHANICAL STABILITY; MEMBRANES; PHYSIOLOGY; POROUS MATERIALS;

CONTROLLED DRUG DELIVERY;

ANTIBIOTIC AGENT; CARBON NANOTUBE; DACARBAZINE; DOXORUBICIN; NANOPARTICLE; PACLITAXEL; POLYGLACTIN; SILICON DIOXIDE;

BIODEGRADABILITY; DEGRADATION KINETICS; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; ELECTRIC FIELD; GASTROINTESTINAL TRACT; HUMAN; HYDROPHILICITY; MICELLE; MICROENCAPSULATION; MICROTECHNOLOGY; NEAR INFRARED SPECTROSCOPY; NONHUMAN; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; PULSATILE DRUG RELEASE; REVIEW; STATIC ELECTRICITY; STOMACH JUICE; SURFACE PROPERTY; VOLUMETRY;

ANIMALS; CARBON; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HUMANS; INORGANIC CHEMICALS; MATERIALS TESTING; POROSITY; SILICATES;

EID: 83655211702     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.132     Document Type: Review

References (112)

1. Drug Delivery Systems to 2012. Study: 2294. Available at: (Accessed September 9, 2010).
2. Na K, Lee ES, Bae YH. Adriamycin loaded pullulan acetate/sulfonamide conjugate nanoparticles responding to tumor pH: pH-dependent cell interaction, internalization and cytotoxicity in vitro. J Control Release 2003, 87:3-13.
3. Shenoy D, Little S, Langer R, Amiji M. Poly(ethylene oxide)-modified poly(β-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. In vitro evaluations. Mol Pharmacol 2005, 2:357-366.
4. Ahmed F, Discher DE. Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles. J Control Release 2004, 96:37-53.
5. Vemula PK, Cruikshank GA, Karp JM, John G. Self-assembled prodrugs: an enzymatically triggered drug-delivery platform. Biomaterials 2009, 30:383-393.
6. Lai CY, Trewyn BG, Jeftinija DM, Jeftinija K, Xu S, Jeftinija S, Lin VSY. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J Am Chem Soc 2003, 125:4451-4459.
7. Hoare T, Santamaria J, Goya GF, Irusta S, Lin D, Lau S, Padera R, Langer R, Kohane DS. A magnetically triggered composite membrane for on-demand drug delivery. Nano Lett 2009, 9:3651-3657.
8. Sershen SR, Westcott SL, Halas NJ, West JL. Temperature-sensitive polymer-nanoshell composites for photothermally modulated drug delivery. J Biomed Mater Res 2000, 51:293-298.
9. Gao Z, Fain HD, Rapoport N. Ultrasound-enhanced tumor targeting of polymeric micellar drug carriers. Mol Pharmacol 2004, 1:317-330.
10. Yin X, Hoffman AS, Stayton PS. Poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers that respond sharply to temperature and pH. Biomacromology 2006, 7:1381-1385.
11. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 2007, 83:761-769.
12. Colilla M, Balas F, Manzano M, Vallet-Regí M. Novel method to enlarge the surface area of SBA-15. Chem Mater 2007, 19:3099-3101.
13. Schulz-Ekloff G, Rathousky J, Zukal A. Mesoporous silica with controlled porous structure and regular morphology. Int J Inorg Mater 1999, 1:97-102.
14. Zhao XS. Novel porous materials for emerging applications. J Mater Chem 2006, 16:623-625.
15. 2 nanotube arrays: an actively controllable drug delivery system. J Am Chem Soc 2009, 131:4230-4232.
16. Serda RE, Mack A, Pulikkathara M, Zaske AM, Chiappini C, Fakhoury JR, Webb D, Godin B, Conyers JL, Liu XW, et al. Cellular association and assembly of a multistage delivery system. Small 2010, 6: 1329-1340.
17. Arruebo M, Vilaboa N, Santamaria J. Drug delivery from internally implanted biomedical devices used in traumatology and in orthopedic surgery. Expert Opin Drug Deliv 2010, 7:1-15.
18. Kresge CT, Leonowicz ME, Roth WJ, Vartuli JC., Beck JS. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 1992, 359:710-712.
19. Huang L, Yan X, Kruk M. Synthesis of ultralarge-pore FDU-12 silica with face-centered cubic structure. Langmuir 2010, 26:14871-14878.
20. Hartmann M. Ordered mesoporous materials for bioadsorption and biocatalysis. Chem Mater 2005, 17:4577-4593.
21. Wang Y, Price AD, Caruso F. Nanoporous colloids: building blocks for a new generation of structured materials. J Mater Chem 2009, 19:6451-6464.
22. Moghimi SM, Hunter C, Murray JC. Nanomedicine: current status and future prospects. FASEB J 2005, 19:311-330.
23. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Ipe BI, Bawendi MG, Frangioni JV. Renal clearance of quantum dots. Nat Biotechnol 2007, 25: 1165-1170.
24. Naeye B, Raemdonck K, Remaut K, Sproat B, Demeester J, De Smedt SC. PEGylation of biodegradable dextran nanogels for siRNA delivery. Eur J Pharm Sci 2010, 40:342-351.
25. Azarmi S, Roa WH, Löbenberg R. Targeted delivery of nanoparticles for the treatment of lung diseases. Adv Drug Deliv Rev 2008, 60:863-875.
26. Ostiguy C, Lapointe G, Trottier M, Ménard L, Cloutier Y, Boutin M, Antoun M, Normand C. Health effects of nanoparticles. Studies and research projects. Report R-451, Montreal: IRSST; 2006.
27. Edwards DA, Hanes J, Caponetti G, Hrkach J, Ben-Jebria A, Eskew ML, Mintzes J, Deaver D, Lotan N, Langer R. Large porous particles for pulmonary drug delivery. Science 1997, 276:1868-1872.
28. Anglin EJ, Cheng L, Freeman WR, Sailor MJ. Porous silicon in drug delivery devices and materials. Adv Drug Deliv Rev 2008, 60:1266-1277.
29. Foraker AB, Walczak RJ, Cohen MH, Boiarski TA, Grove CF, Swaan PW. Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers. Pharmacol Res 2003, 20:110-116.
30. Gu L, Park JH, Duong KH, Ruoslahti E, Sailor MJ. Magnetic luminescent porous silicon microparticles for localized delivery of molecular drug payloads. Small 2010, 6:2546-2552.
31. Kleps I, Bragaru A, Ignat T, Miu M, Simion M, Craciunoiu F, Danila M, Tirifon E, Anghel R, Popovici A, et al. Nanostructured microcarriers based on silicon for drug delivery. Semiconductor Conference, 2009. CAS 2009 International, Sinaia, Romania.
32. Tasciotti E, Plant K, Bhavane R, Liu X, Leonard AD, Price K, Cheng MMC, Decuzzi P, Tour JM, Robertson F, et al. Nanoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol 2008, 3: 151-157.
33. Lu J, Liong M, Zink JI, Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 2007, 3:1341-1346.
34. Xia T, Kovochich M, Liong M, Meng H, Kabehie S, George S, Zink JI, Nel AE. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 2009, 10: 3273-3286.
35. Park IY, Kim IY, Yoo MK, Choi YJ, Cho MH, Cho CS. Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery. Int J Pharm 2008, 359:280-287.
36. Slowing II, Trewyn BG, Lin VSY. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J Am Chem Soc 2007, 129: 8845-8849.
37. Vallet-Regí M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed 2007, 46:7548-7558.
38. Tang Q, Xu Y, Wu D, Sun Y. Hydrophobicity-controlled drug delivery system from organic modified mesoporous silica. Chem Lett 2006, 35:474-475.
39. Lin Q, Huang Q, Li C, Bao C, Liu Z, Li F, Zhu L. Anticancer drug release from a mesoporous silica based nanophotocage regulated by either a one- or two-photon process. J Am Chem Soc 2010, 132: 10645-10647.
40. Qian J, Gharibi A, He S. Colloidal mesoporous silica nanoparticles with protoporphyrin IX encapsulated for photodynamic therapy. J Biomed Opt 2009, 14:014012.
41. Vivero-Escoto JL, Slowing II, Wu C, Lin VSY. Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. J Am Chem Soc 2009, 131: 3462-3463.
42. Casasús R, Climent E, Marcos MD, Martínez-Máñez R, Sancenón F, Soto J, Amorós P, Cano J, Ruiz E. Dual aperture control on pH- and anion-driven supramolecular nanoscopic hybrid gate-like ensembles. J Am Chem Soc 2008, 130:1903-1917.
43. Leung KCF, Nguyen TD, Stoddart JF, Zink JI. Supramolecular nanovalves controlled by proton abstraction and competitive binding. Chem Mater 2006, 18:5919-5928.
44. Patel K, Angelos S, Dichtel WR, Coskun A, Yang YW, Zink JI, Stoddart JF. Enzyme-responsive snap-top covered silica nanocontainers. J Am Chem Soc 2008, 130: 2382-2383.
45. Nguyen TD, Liu Y, Saha S, Leung KCF, Stoddart JF, Zink JI. Design and optimization of molecular nanovalves based on redox-switchable bistable rotaxanes J Am Chem Soc 2007, 129:626-634.
46. Climent E, Bernardos A, Martínez-Mañez R, Maquieira A, Marcos MD, Pastor-Navarro N, Puchades R, Sancenón F, Soto J, Amorós P. Controlled delivery systems using antibody-capped mesoporous nanocontainers. J Am Chem Soc 2009, 131:14075-14080.
47. Nguyen TD, Leung KCF, Liong M, Liu Y, Stoddart JF, Zink JI. Versatile supramolecular nanovalves reconfigured for light activation. Adv Funct Mater 2007, 17:2101-2110.
48. Climent E, Martínez-Máñez R, Sancenón F, Marcos MD, Soto J, Maquieira A, Amorós P. Controlled delivery using oligonucleotide-capped mesoporous silica nanoparticles. Angew Chem Int Ed 2010, 49:7281-7283.
49. Giri S, Trewyn BG, Stellmaker MP, Lin VSY. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew Chem Int Ed 2005, 44:5038-5044.
50. Lu J, Choi E, Tamanoi F, Zink JI. Light-activated nanoimpeller-controlled drug release in cancer cells. Small 2008, 4:421-426.
51. You YZ, Kalebaila KK, Brock SL, Oupicky D. Temperature-controlled uptake and release in PNIPAM-modified porous silica nanoparticles. Chem Mater 2008, 20:3354-3359.
52. Aznar E, Marcos MD, Martínez-Máñez R, Sancenón F, Soto J, Amorós P, Guillem C. pH- and photo-switched release of guest molecules from mesoporous silica supports. J Am Chem Soc 2009, 131: 6833-6843.
53. 2 nanoparticles. Chem Commun 2010, 46:7513-7515.
54. Roy I, Ohulchanskyy TY, Pudavar HE, Bergey EJ, Oseroff AR, Morgan J, Dougherty TJ, Prasad PN. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J Am Chem Soc 2003, 125:7860-7865.
55. Huo Q, Liu J, Wang LQ, Jiang Y, Lambert TN, Fang E. A new class of silica cross-linked micellar core-shell nanoparticles. J Am Chem Soc 2006, 128:6447-6453.
56. Xu ZP, Zeng QH, Lu GQ, Yu AB. Inorganic nanoparticles as carriers for efficient cellular delivery. Chem Eng Sci 2006, 61:1027-1040.
57. Gemeinhart RA, Luo D, Saltzman WM. Cellular fate of a modular DNA delivery system mediated by silica nanoparticles. Biotechnol Prog 2005, 21: 532-537.
58. Luo D, Saltzman WM. Enhancement of transfection by physical concentration of DNA at the cell surface. Nat Biotechnol 2000, 18:893-895.
59. Torney F, Trewyn BG, Lin VSY, Wang K. Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat Nanotechnol 2007, 2:295-300.
60. Slowing II, Trewyn BG, Giri S, Lin VSY. Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv Funct Mater 2007, 17: 1225-1236.
61. Kim TW, Chung PW, Slowing II, Tsunoda M, Yeung ES, Lin VS. Structurally ordered mesoporous carbon nanoparticles as transmembrane delivery vehicle in human cancer cells. Nano Lett 2008, 8:3724-3727.
62. Sevilla M, Valle-Vigon P, Tartaj P, Fuertes AB. Magnetically separable bimodal mesoporous carbons with a large capacity for the immobilization of biomolecules. Carbon 2009, 47:2519-2527.
63. Horcajada P, Chalati T, Serre C, Gillet B, Sebrie C, Baati T, Eubank JF, Heurtaux D, Clayette P, Kreuz C, et al. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Nat Mater 2010, 9:172-178.
64. An J, Geib SJ, Rosi NL. Cation-triggered drug release from a porous zinc-adeninate metal-organic framework. J Am Chem Soc 2009, 131:8376-8377.
65. Wagner V, Dullaart A, Bock AK, Zweck A. The emerging nanomedicine landscape. Nat Biotech 2006, 24:1211-1217.
66. Rigby SP, Fairhead M, van der Walle CF. Engineering silica particles as oral drug delivery vehicles. Curr Pharm Des 2008, 14:1821-1831.
67. Van Speybroeck M, Barillaro V, Thi TD, Mellaerts R, Martens J, Humbeeck JV, Vermant J, Annaert P, den Mooter GV, Augustijns P. Ordered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugs. J Pharm Sci 2009, 98:2648-2658.
68. Jain SK, Awasthi AM, Jain NK, Agrawal GP. Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization. J Control Release 2005, 107:300-309.
69. Carino IS, Pascua L, Testa F, Aiello R, Puoci F, Iemma F, Picci N. Silica-based mesoporous materials as drug delivery system for methotrexate release. Drug Deliv 2007, 14:491-495.
70. Ahmeda A, Bonnera C, Desai TA. Bioadhesive microdevices with multiple reservoirs: a new platform for oral drug delivery. J Control Release 2002, 81: 291-306.
71. Fan J, Lei J, Wang L, Yu C, Tu B, Zhao D. Rapid and high-capacity immobilization of enzymes based on mesoporous silicas with controlled morphologies. Chem Commun 2003, 2140-2141.
72. Urrego S, Serra E, Alfredsson V, Blanco RM, Díaz I. Bottle-around-the-ship: a method to encapsulate enzymes in ordered mesoporous materials Micropor Mesopor Mater 2010, 129:173-178.
73. Lei C, Shin Y, Liu J, Ackerman E. Entrapping enzyme in a functionalized nanoporous support. J Am Chem Soc 2002, 124:11242-11243.
74. Hudson S, Cooney J, Hodnett BK, Magner E. Chloroperoxidase on periodic mesoporous organosilanes: immobilization and reuse. Chem Mater 2007, 19:2049-2055.
75. Zhu Y, Kaskel S, Shi J, Wage T, van Pée KH. Immobilization of Trametes Versicolor Laccase on magnetically separable mesoporous silica spheres. Chem Mater 2007, 19:6408-6413.
76. Fadnavis NW, Bhaskar V, Kantam ML, Choudary BM. Highly efficient "tight fit" immobilization of α-chymotrypsin in mesoporous MCM-41: a novel approach using precursor immobilization and activation. Biotechnol Prog 2003, 19:346-351.
77. Wang Y, Caruso F. Mesoporous silica spheres as supports for enzyme immobilization and encapsulation. Chem Mater 2005, 17:953-961.
78. Gao F, Botella P, Corma A, Blesa J, Dong L. Monodispersed mesoporous silica nanoparticles with very large pores for enhanced adsorption and release of DNA. J Phys Chem B 2009, 113:1796-1804.
79. Balkus KJ, Gabrielov AG. Zeolite encapsulated metal complexes. J Incl Phenom Macrocycl Chem 1995, 21:159-184.
80. Martin CR, Kohli P. The emerging field of nanotube biotechnology. Nat Rev Drug Discov 2003, 2:29-37.
81. Kapoor S, Bhattacharyya AJ. Ultrasound-triggered controlled drug delivery and biosensing using silica nanotubes. J Phys Chem C 2009, 113:7155-7163.
82. Hillebrenner H, Buyukserin F, Kang M, Mota MO, Stewart JD, Martin CR. Corking nano test tubes by chemical self-assembly. J Am Chem Soc 2006, 128: 4236-4237.
83. Popat KC, Eltgroth M, LaTempa TJ, Grimes CA, Desai TA. Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials 2007, 28:4880-4888.
84. Leoni L, Desai TA. Nanoporous biocapsules for the encapsulation of insulinoma cells: biotransport and biocompatibility considerations. IEEE Trans Biomed Eng 2001, 48:11-18.
85. Tang SH, Huang XQ, Chen XL, Zheng NF. Hollow mesoporous zirconia nanocapsules for drug delivery. Adv Funct Mater 2010, 20:2442-2447.
86. Chen Y, Chen H, Zeng D, Tian Y, Chen F, Feng J, Shi J. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery. ACS Nano 2010, 4:6001-6013.
87. Lin YS, Haynes CL. Impacts of mesoporous silica nanoparticles size, pore ordering, and pore integrity on hemolytic activity. J Am Chem Soc 2010, 132:4834-4842.
88. Kong SD, Zhang W, Lee JH, Brammer K, Lal R, Karin M, Jin S. Magnetically vectored nanocapsules for tumor penetration and remotely switchable on-demand drug release. Nano Lett 2010, 10: 5088-5092.
89. Cheng K, Sun S. Recent advances in syntheses and therapeutic applications of multifunctional porous hollow nanoparticles. Nano Today 2010, 5:183-196.
90. Xu ZP, Zeng QH, Lu GQ, Yu AB. Inorganic nanoparticles as carriers for efficient cellular delivery. Chem Eng Sci 2006, 61:1027-1040.
91. Santini JT, Cima MJ, Langer R. A controlled-release microchip. Nature 1999, 397:335-338.
92. Martin F, Walczak R, Boiarski A, Cohen M, West T, Cosentino C, Shapiro J, Ferrari M. Tailoring width of microfabricated nanochannels to solute size can be used to control diffusion kinetics. J Control Release 2005, 102:123-133.
93. Arruebo M, Irusta S, Pérez LM, Lalueza P, Puértolas JS, Gracia-Villa L, García-Alvarez F, Monzón M, Santamaría J. Bone implant with porous boundaries, for the controlled drug release. Spanish patent application P200931157, 2009.
94. Wheatley PS, Butler AR, Crane MS, Fox S, Xiao B, Rossi AG, Megson IL, Morris RE. NO-releasing zeolites and their antithrombotic properties. J Am Chem Soc 2006, 128:502-509.
95. Yeung KL, Wong L, Sun W, Leung WK, Lai WY, Chan NW. Molecular sieve and zeolite microneedles and preparation thereof. Patent number(s): WO2007095859-A1; US2007280878-A1; CN1013 89374-A, 2007.
96. Rajaraman S, Henderson HT. A unique fabrication approach for microneedles using coherent porous silicon technology. Sens Actuators B Chem 2005, 105: 443-448.
97. Shirkhanzadeh M. Microneedles coated with porous calcium phosphate ceramics: effective vehicles for transdermal delivery of solid trehalose. J Mater Sci Mater Med 2005, 16:37-45.
98. Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 2004, 56:581-587.
99. Strasinger CL, Scheff NN, Wu J, Hinds BJ, Stinchcomb AL. Carbon nanotube membranes for use in the transdermal treatment of nicotine addiction and opioid withdrawal symptoms. J Subst Abuse Res Treat 2009, 3:31-39.
100. Hudson SP, Padera RF, Langer R, Kohane DS. The biocompatibility of mesoporous silicates. Biomaterials 2008, 29:4045-4055.
101. Huang X, Zhuang J, Teng X, Li L, Chen D, Yan X, Tang F. The promotion of human malignant melanoma growth by mesoporous silica nanoparticles through decreased reactive oxygen species. Biomaterials 2010, 31:6142-6153.
102. Lu J, Liong M, Li Z, Zink JI, Tamanoi F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 2010, 6:1794-1805.
103. Wörle-Knirsch M, Pulskamp K, Krug HF. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. J Nano Lett 2006, 6:1261-1268.
104. Davoren M, Herzog E, Casey A, Cottineau B, Chambers G, Byrne HJ, Lyng FM. In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells. Toxicol in Vitro 2007, 21: 438-448.
105. Shaw SY, Westly EC, Pittet MJ, Subramanian A, Schreiber SL, Weissleder R. Perturbational profiling of nanomaterial biologic activity. Proc Natl Acad Sci 2008, 105:7387-7392.
106. Adiseshaiah PP, Hall JB, McNeil SE. Nanomaterial standards for efficacy and toxicity assessment. WIREs Nanomed Nanobiotechnol 2009, 2:99-112.
107. Hartmann M, Jung D. Immobilization of proteins and enzymes, mesoporous supports. Encyclopedia of Industrial Biotechnology: Bioprocess, Bioseparation, and Cell Technology, Vol 7. New York: John Wiley & Sons; 2009, 1-30.
108. Kohane DS, Langer R. Biocompatibility and drug delivery systems. Chem Sci 2010, 1:441-446.
109. Sayes CM, Warheit DB. Characterization of nanomaterials for toxicity assessment. WIREs Nanomed Nanobiotechnol 2009, 1:660-670.
110. Shi J, Votruba AR, Farokhzad OC, Langer R. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett 2010, 10:3223-3230.
111. Strømme M, Brohede U, Atluri R, Garcia-Bennett AE. Mesoporous silica-based nanomaterials for drug delivery: evaluation of structural properties associated with release rate. WIREs Nanomed Nanobiotechnol 2009, 1:140-148.
112. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 2008 83:761-769.